JP2009545302A5 - - Google Patents

Download PDF

Info

Publication number
JP2009545302A5
JP2009545302A5 JP2009522328A JP2009522328A JP2009545302A5 JP 2009545302 A5 JP2009545302 A5 JP 2009545302A5 JP 2009522328 A JP2009522328 A JP 2009522328A JP 2009522328 A JP2009522328 A JP 2009522328A JP 2009545302 A5 JP2009545302 A5 JP 2009545302A5
Authority
JP
Japan
Prior art keywords
pluripotent
rat
cell
cells
pluripotent rat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009522328A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009545302A (ja
JP5456467B2 (ja
Filing date
Publication date
Priority claimed from GBGB0615327.4A external-priority patent/GB0615327D0/en
Application filed filed Critical
Publication of JP2009545302A publication Critical patent/JP2009545302A/ja
Publication of JP2009545302A5 publication Critical patent/JP2009545302A5/ja
Application granted granted Critical
Publication of JP5456467B2 publication Critical patent/JP5456467B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009522328A 2006-08-01 2007-08-01 ラットおよび他種由来の多能性細胞 Expired - Fee Related JP5456467B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB0615327.4A GB0615327D0 (en) 2006-03-30 2006-08-01 Culture medium containing kinase inhibitors and uses thereof
GB0615327.4 2006-08-01
GBGB0700479.9A GB0700479D0 (en) 2006-08-01 2007-01-10 Culture medium containing kinase inhibitors, and uses thereof
GB0700479.9 2007-01-10
PCT/GB2007/002913 WO2008015418A2 (en) 2006-08-01 2007-08-01 Pluripotent cells from rat and other species

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013127052A Division JP2013176400A (ja) 2006-08-01 2013-06-17 ラットおよび他種由来の多能性細胞

Publications (3)

Publication Number Publication Date
JP2009545302A JP2009545302A (ja) 2009-12-24
JP2009545302A5 true JP2009545302A5 (cg-RX-API-DMAC7.html) 2010-05-06
JP5456467B2 JP5456467B2 (ja) 2014-03-26

Family

ID=37809760

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009522328A Expired - Fee Related JP5456467B2 (ja) 2006-08-01 2007-08-01 ラットおよび他種由来の多能性細胞
JP2013127052A Pending JP2013176400A (ja) 2006-08-01 2013-06-17 ラットおよび他種由来の多能性細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013127052A Pending JP2013176400A (ja) 2006-08-01 2013-06-17 ラットおよび他種由来の多能性細胞

Country Status (7)

Country Link
US (2) US8431395B2 (cg-RX-API-DMAC7.html)
EP (1) EP2049654A2 (cg-RX-API-DMAC7.html)
JP (2) JP5456467B2 (cg-RX-API-DMAC7.html)
CN (2) CN101657535B (cg-RX-API-DMAC7.html)
AU (1) AU2007280216B2 (cg-RX-API-DMAC7.html)
GB (3) GB0615327D0 (cg-RX-API-DMAC7.html)
WO (1) WO2008015418A2 (cg-RX-API-DMAC7.html)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7682828B2 (en) 2003-11-26 2010-03-23 Whitehead Institute For Biomedical Research Methods for reprogramming somatic cells
US8357666B2 (en) * 2005-08-01 2013-01-22 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through RNA interference
EP1999249B8 (en) * 2006-03-30 2012-02-15 The University Court Of The University of Edinburgh Culture medium containing kinase inhibitors. and uses thereof
MX352541B (es) 2007-04-07 2017-11-29 Whitehead Inst Biomedical Res Reprogramación de células somáticas.
US9080145B2 (en) 2007-07-01 2015-07-14 Lifescan Corporation Single pluripotent stem cell culture
CN101918541A (zh) * 2007-07-18 2010-12-15 塞拉提斯股份公司 衍生自hBS细胞的心肌细胞样细胞簇
CA2695225C (en) 2007-07-31 2021-06-01 Lifescan, Inc. Differentiation of human embryonic stem cells to pancreatic endocrine
WO2009032194A1 (en) 2007-08-31 2009-03-12 Whitehead Institute For Biomedical Research Wnt pathway stimulation in reprogramming somatic cells
CA2718904C (en) 2008-03-17 2017-01-03 The Scripps Research Institute Combined chemical and genetic approaches for generation of induced pluripotent stem cells
AU2009233845A1 (en) * 2008-04-07 2009-10-15 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of a small molecule modulator
CA2969377C (en) 2008-06-13 2019-12-03 Whitehead Institute For Biomedical Research Programming and reprogramming of cells
EP2942392B1 (en) 2008-06-30 2018-10-03 Janssen Biotech, Inc. Differentiation of pluripotent stem cells
EP2369916A4 (en) * 2008-12-01 2013-04-10 Univ Texas PREPARATION AND USE OF SPERMATOGONIAL STEM CELL LINES FROM THE RAT
ES2645869T3 (es) 2008-12-17 2017-12-11 The Scripps Research Institute Generación y mantenimiento de células madre
EP2421956A4 (en) * 2009-04-24 2013-10-02 Whitehead Biomedical Inst COMPOSITIONS AND METHODS FOR OBTAINING OR CULTURING PLURIPOTENTER CELLS
JP5808331B2 (ja) * 2009-10-16 2015-11-10 ザ スクリプス リサーチ インスティテュート 多能性細胞の誘導法
EP2508595B1 (en) 2009-12-01 2016-11-23 National Cancer Center Method for constructing chimeric rat using rat embryonic stem cells
EP2505639B1 (en) * 2009-12-29 2018-09-19 Takeda Pharmaceutical Company Limited Method for manufacturing pancreatic-hormone-producing cells
ES2624780T3 (es) 2010-03-31 2017-07-17 The Scripps Research Institute Reprogramación de células
US20130059375A1 (en) * 2010-04-02 2013-03-07 Riken Method for preparing es cells
ES2685171T3 (es) 2010-06-14 2018-10-05 The Scripps Research Institute Reprogramación de células a un nuevo destino
CN102344490B (zh) * 2010-07-30 2014-03-05 中国科学院上海生命科学研究院 抗小鼠Stk40的多克隆抗体及其制备
NZ607608A (en) * 2010-08-09 2014-03-28 Takeda Pharmaceuticals Co Method of producing pancreatic hormone-producing cells
JP6090855B2 (ja) * 2010-11-17 2017-03-08 国立大学法人京都大学 心筋細胞および/または心筋前駆細胞増殖剤ならびに心筋細胞および/または心筋前駆細胞の増殖方法
KR101975688B1 (ko) 2010-12-22 2019-05-07 페이트 세러퓨틱스, 인코포레이티드 단세포 분류 및 iPSC의 증강된 재프로그래밍을 위한 세포 배양 플랫폼
US20140127133A1 (en) * 2011-01-24 2014-05-08 Claude Brodski Method for evaluating a mental disorder
US20140234963A1 (en) 2011-06-21 2014-08-21 Novo Nordisk A/S Efficient induction of definitive endoderm from pluripotent stem cells
SI3865581T1 (sl) 2011-08-05 2024-12-31 Regeneron Pharmaceuticals, Inc. Miši s humanizirano univerzalno lahko verigo
PL2793567T3 (pl) * 2011-12-20 2019-09-30 Regeneron Pharmaceuticals, Inc. Myszy z humanizowanym łańcuchem lekkim
PT2847335T (pt) 2012-04-25 2018-09-28 Regeneron Pharma Alvejamento mediado por nuclease com vetores de alvejamento grandes
EP3561050B1 (en) 2013-02-20 2021-12-08 Regeneron Pharmaceuticals, Inc. Genetic modification of rats
HUE040575T2 (hu) * 2013-04-16 2019-03-28 Regeneron Pharma A patkány genom célzott módosítása
WO2014197934A1 (en) 2013-06-14 2014-12-18 The University Of Queensland Renal progenitor cells
US9546384B2 (en) 2013-12-11 2017-01-17 Regeneron Pharmaceuticals, Inc. Methods and compositions for the targeted modification of a mouse genome
KR102670874B1 (ko) 2014-03-04 2024-05-31 페이트 세러퓨틱스, 인코포레이티드 개선된 재프로그래밍 방법 및 세포 배양 플랫폼
CA2945263A1 (en) 2014-04-09 2015-10-15 Christopher Rudd Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
JP6652334B2 (ja) 2014-05-31 2020-02-19 Jcrファーマ株式会社 ウリジンとn−アセチル−d−マンノサミンとを含有する培地
LT3152312T (lt) 2014-06-06 2020-04-27 Regeneron Pharmaceuticals, Inc. Tikslinio lokuso modifikavimo būdai ir kompozicijos
EP3461885B1 (en) 2014-06-26 2021-10-20 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modifications and methods of use
HUE044907T2 (hu) 2014-11-21 2019-11-28 Regeneron Pharma Módszerek és készítmények célzott genetikai módosításhoz, párosított mutató RNS-ek használatával
NZ732895A (en) 2014-12-19 2022-05-27 Regeneron Pharma Methods and compositions for targeted genetic modification through single-step multiple targeting
SG11201707858TA (en) * 2015-03-30 2017-10-30 Ajinomoto Kk Human serum albumin-containing culture medium for growth of neural stem cells
EP3362570A4 (en) 2015-10-16 2019-03-20 Fate Therapeutics, Inc. PLATFORM FOR THE INDUCTION AND MAINTENANCE OF BASIC STATUS PLURIPOTENCE
MA45479A (fr) 2016-04-14 2019-02-20 Janssen Biotech Inc Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen
DK3519558T3 (da) 2016-09-28 2023-11-13 Organovo Inc Anvendelse af modificeret nyrevæv i assays
WO2019208787A1 (ja) * 2018-04-27 2019-10-31 株式会社カネカ 原始腸管細胞の製造方法
CN113316634A (zh) * 2018-11-21 2021-08-27 新加坡科技研究局 成熟的库普弗细胞的产生
CN111238897B (zh) * 2020-02-18 2023-03-28 上海市皮肤病医院 生物标本的处理方法与处理剂
JP2023532061A (ja) * 2020-07-02 2023-07-26 アクセルタ リミテッド 遅延胚由来の哺乳類家畜多能性幹細胞
EP4386082A4 (en) * 2021-08-10 2025-08-20 Kaneka Corp PROCESS FOR THE PRODUCTION OF PLURIPOTENT STEM CELLS
CN115927166A (zh) * 2022-12-06 2023-04-07 云南省第一人民医院 一种大鼠原始内胚层干细胞分离建系的方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9308271D0 (en) 1993-04-21 1993-06-02 Univ Edinburgh Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
AU7677894A (en) 1993-08-30 1995-03-22 Northwestern University Rat pluripotent embryonic stem cells and method of obtaining and using same
CA2267220A1 (en) 1996-10-11 1998-04-23 The Texas A & M University System Methods for the generation of primordial germ cells and transgenic animal species
US6214795B1 (en) 1996-11-12 2001-04-10 Praecis Pharmaceuticals, Inc. Peptide compounds useful for modulating FGF receptor activity
WO1998030679A1 (en) 1997-01-10 1998-07-16 Life Technologies, Inc. Embryonic stem cell serum replacement
WO1999027076A1 (en) 1997-11-25 1999-06-03 Arc Genomic Research Pluripotent embryonic stem cells and methods of obtaining them
GB9819912D0 (en) 1998-09-11 1998-11-04 Univ Edinburgh Propagation and/or derivation of embryonic stem cells
US7455983B2 (en) 2000-01-11 2008-11-25 Geron Corporation Medium for growing human embryonic stem cells
US20020045260A1 (en) 2000-10-17 2002-04-18 Shih-Chieh Hung Method of isolating mesenchymal stem cells
JP2002176973A (ja) 2000-12-14 2002-06-25 Shigeo Saito 哺乳動物胚性幹細胞とその樹立方法並びにその継代培養方法
AU2003210405A1 (en) 2002-03-05 2003-09-16 Artemis Pharmaceuticals Gmbh Inbred embryonic stem-cell derived mice
GB0210539D0 (en) 2002-05-08 2002-06-19 Univ Edinburgh Control of es cell self renewal and lineage specification, and medium therefor
US7338957B2 (en) 2003-08-28 2008-03-04 Irm Llc Compounds and compositions as protein kinase inhibitors
SG149061A1 (en) * 2003-12-23 2009-01-29 Cythera Inc Definitive endoderm
US8137966B2 (en) 2004-03-04 2012-03-20 Dainippon Sumitomo Pharma Co., Ltd. Rat embryonic stem cell
WO2005094830A1 (en) 2004-03-30 2005-10-13 Pfizer Products Inc. Combinations of signal transduction inhibitors
WO2005110438A2 (en) 2004-04-15 2005-11-24 Massachusetts Institute Of Technology Methods and products related to the intracellular delivery of polysaccharides
WO2006026473A2 (en) 2004-08-25 2006-03-09 University Of Georgia Research Foundation, Inc. METHODS AND COMPOSITIONS UTILIZING MYC AND GSK3ß TO MANIPULATE THE PLURIPOTENCY OF EMBRYONIC STEM CELLS
CN101238129A (zh) 2005-06-10 2008-08-06 Irm责任有限公司 维持胚胎干细胞多能性的化合物
JP2009517085A (ja) 2005-11-28 2009-04-30 チョンウェ ファーマ コーポレイション 培養における細胞の無血清増殖
EP1999249B8 (en) 2006-03-30 2012-02-15 The University Court Of The University of Edinburgh Culture medium containing kinase inhibitors. and uses thereof
WO2007113705A1 (en) * 2006-04-03 2007-10-11 Koninklijke Philips Electronics N. V. Determining tissue surrounding an object being inserted into a patient
EP2018167A4 (en) 2006-05-15 2010-07-14 Irm Llc COMPOSITIONS AND METHODS AS INHIBITORS OF FGF RECEPTOR KINASES

Similar Documents

Publication Publication Date Title
JP2009545302A5 (cg-RX-API-DMAC7.html)
JP2013176400A5 (cg-RX-API-DMAC7.html)
Li et al. Androgenetic haploid embryonic stem cells produce live transgenic mice
Huijbers et al. Rapid target gene validation in complex cancer mouse models using re‐derived embryonic stem cells
CN102943092B (zh) 一种通用型PiggyBac转座子转基因载体及其制备方法
BR112015019950B1 (pt) Método para gerar linhagem de células-tronco embrionárias (es) de rato, e, cultura in vitro
JP2008516633A (ja) 遺伝的改変についてホモ接合性の動物を生み出すための方法
CN103361304B (zh) 孤雄单倍体干细胞系及其制法和应用
JP2015500637A5 (cg-RX-API-DMAC7.html)
WO2010030986A3 (en) Clean genome bactofection
JP2019500910A5 (cg-RX-API-DMAC7.html)
US9167805B2 (en) Method of establishing mouse strain
US11085020B2 (en) Mammalian haploid embryonic stem cells
Cui et al. Current advances in haploid stem cells
Cui et al. MED20 is essential for early embryogenesis and regulates NANOG expression
Wang et al. ‘Artificial spermatid’-mediated genome editing
MY193790A (en) Cloned non-human animals free of selective markers
Shi et al. Haploid embryonic stem cells: an ideal tool for mammalian genetic analyses
Aizawa et al. Polyploidy of semi-cloned embryos generated from parthenogenetic haploid embryonic stem cells
Araki et al. Establishment of germline-competent embryonic stem cell lines from the MSM/Ms strain
Wang et al. Wnt Inhibition Safeguards Porcine Embryonic Stem Cells From the Acquisition of Extraembryonic Endoderm Cell Fates
Zhang et al. Rapidly generating knockout mice from H19-Igf2 engineered androgenetic haploid embryonic stem cells
An et al. Derivation of pluripotent stem cells from nascent undifferentiated teratoma
Bai et al. Spermatogenic cell-specific gene mutation in mice via CRISPR-Cas9
Hirabayashi et al. Haploid embryonic stem cell lines derived from androgenetic and parthenogenetic rat blastocysts